Financials data is unavailable for this security.
Cash flow in USDView more
In 2023, cash reserves at Kairos Pharma Ltd fell by 344.00k. However, the company earned 81.00k from its operations for a Cash Flow Margin of --. In addition the company used on investing activities and also paid 425.00k in financing cash flows.
Cash flow per share | -0.0815 |
---|---|
Price/Cash flow per share | -- |
Book value per share | 0.2594 |
---|---|
Tangible book value per share | 0.239 |
More ▼
Balance sheet in USDView more
Current ratio | 2.84 |
---|---|
Quick ratio | -- |
Total debt/total equity | 0.0426 |
---|---|
Total debt/total capital | 0.0409 |
More ▼